SpringWorks Therapeutics
Senior Statistical Programmer at SpringWorks supports clinical development by producing and validating statistical programs and datasets for analysis and regulatory submission. The role focuses on maintaining programming standards, ensuring data integrity and compliance with relevant guidelines, and providing technical leadership and mentorship within the statistical programming function. The position is part of a commercial-stage biopharmaceutical company working on therapies for rare tumors.
Headquarters
Stamford, Connecticut, United States
Company Size
201-500 employees
Founded
2017
SpringWorks Therapeutics, a healthcare company of Merck KGaA, Darmstadt, Germany, is a commercial-stage biopharmaceutical company focused on targeted oncology, including rare oncology and BCMA combinations in multiple myeloma. The company develops and commercializes treatments for patients with devastating cancers and rare diseases, with approved medicines including OGSIVEO® (nirogacestat) for desmoid tumors and EZMEKLY® (mirdametinib) for NF1-associated plexiform neurofibromas. SpringWorks combines scientific rigor with a patient-centric, urgency-driven approach to unlock the full potential of targeted oncology.
Merck Completes Acquisition of SpringWorks Therapeutics to Accelerate Sustainable Growth of its Healthcare Business
Jul 1, 2025
Merck KGaA drops pipeline assets from SpringWorks buyout, Hengrui licensing deal
1 week ago
Merck completes $3.4bn acquisition of SpringWorks Therapeutics
Jul 2, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for SpringWorks Therapeutics.
Biopharma Co. Can't Beat Former Exec's Age, Race Bias Suit
3 days ago